Prostate cancer treated with brachytherapy; an exploratory study of dose-dependent biomarkers and quality of life

BACKGROUND: Low-dose-rate permanent prostate brachytherapy (PPB) is an attractive treatment option for patients with localised prostate cancer with excellent outcomes. As standard CT-based post-implant dosimetry often correlates poorly with late treatment-related toxicity, this exploratory (proof of...

Descripción completa

Detalles Bibliográficos
Autores principales: Osman, Sarah O. S., Horn, Simon, Brady, Darren, McMahon, Stephen J., Yoosuf, Ahamed B. Mohamed, Mitchell, Darren, Crowther, Karen, Lyons, Ciara A., Hounsell, Alan R., Prise, Kevin M., McGarry, Conor K., Jain, Suneil, O’Sullivan, Joe M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348795/
https://www.ncbi.nlm.nih.gov/pubmed/28288658
http://dx.doi.org/10.1186/s13014-017-0792-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348795/
https://www.ncbi.nlm.nih.gov/pubmed/28288658
http://dx.doi.org/10.1186/s13014-017-0792-1

Ejemplares similares